<DOC>
	<DOCNO>NCT02044549</DOCNO>
	<brief_summary>compare effectiveness tolerability carbetocin versus syntometrine prevention Postpartum hemorrhage cesarean section</brief_summary>
	<brief_title>Carbetocin Versus Syntometrine Prevention Postpartum Hemorrhage After Cesarean Section</brief_title>
	<detailed_description>A double blind randomize study conduct 450 pregnant subject randomly either single 100 Î¼g IV dose carbetocin ( 150 woman ) combination 5 IU oxytocin 0.2 mg ergometrine ( 300 woman ) fetal extraction placental removal . Prevention postpartum haemorrhage ( PPH ) cesarean section ( CS ) evaluate measurement drop Hemoglobin hematocrit , incidence PPH number subject need additional oxytocic</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Carbetocin</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<mesh_term>Syntometrine</mesh_term>
	<mesh_term>Ergonovine</mesh_term>
	<criteria>All participant 37 40 week gestational age Noncomplicated pregnancy . Participants placenta previa Patients coagulopathy preeclamptic woman know sensitivity oxytocin methergine exclude</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Carbetocin</keyword>
	<keyword>syntometrine</keyword>
	<keyword>postpartum hemorrhage</keyword>
	<keyword>cesarean section</keyword>
</DOC>